TRIB
Trinity Biotech
TRIB
TRIB
56 hedge funds and large institutions have $89.6M invested in Trinity Biotech in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
40% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 20
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $101K
Holders
56
Holding in Top 10
2
Calls
–
Puts
$101K
Top Buyers
| 1 | +$8.49M | |
| 2 | +$1.38M | |
| 3 | +$809K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$446K |
| 5 |
Renaissance Technologies
New York
|
+$398K |
Top Sellers
| 1 | -$1.92M | |
| 2 | -$1.42M | |
| 3 | -$866K | |
| 4 |
RA
Royce & Associates
New York
|
-$667K |
| 5 |
JPMorgan Chase & Co
New York
|
-$572K |